The FINANCIAL — NYSE Euronext (NYX) on December 6 announced trading volumes for its global derivatives and cash equities exchanges for November 2010[1].
"Global derivatives average daily volume (“ADV”) of 8.2 million contracts traded per day in November 2010 increased 12.6% versus the prior year, and increased 9.9% from October 2010 levels. The increase in global derivatives ADV versus prior year levels was driven primarily by a 28.5% increase in U.S. equity options ADV. Cash equities ADV in November 2010 was mixed, with European cash ADV increasing 16.6% and U.S. cash trading volumes decreasing 4.8% from November 2009 levels," NYSE Euronext informs.
Highlights
NYSE Euronext global derivatives ADV in November 2010 of 8.2 million contracts increased 12.6% compared to November 2009 and increased 9.9% from October 2010 levels. Open interest for the European derivatives businesses at the end of November 2010 was 82.8 million contracts, a decrease of 9.8% compared to November 2009, but an increase of 0.9% from October 2010 levels.
NYSE Euronext European derivatives products ADV in November 2010 of 4.4 million contracts increased 1.6% compared to November 2009 and increased 23.3% from October 2010 levels. Total European fixed income products ADV in November 2010 of 2.0 million contracts decreased 13.5% compared to November 2009 and increased 0.5% from October 2010. Total equity products ADV of 2.3 million contracts in November 2010 increased 18.4% compared to November 2009 and increased 55.9% from October 2010. Total commodities products ADV of 67,000 contracts in November 2010 increased 51.9% compared to November 2009.
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.9 million contracts in November 2010 increased 28.5% compared to November 2009 levels, but decreased 2.1% from October 2010. NYSE Euronext’s U.S. options exchanges accounted for 24.7% of total U.S. consolidated equity options trading in November 2010, in-line with November 2009, but below the 25.9% recorded in October 2010.
NYSE Euronext European cash products ADV of 1.5 million transactions in November 2010 increased 16.6% compared to November 2009 and increased 6.9% from October 2010.
NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.3 billion shares in November 2010 decreased 4.8% compared to November 2009 and decreased 1.1% compared to October 2010. NYSE Euronext’s Tape A matched market share in November 2010 was 36.1%, down from 36.8% in November 2009, but up from 35.2% in October 2010.
There were a total of 22 trading days in Europe and 21 trading days in the U.S. in November 2010, compared to 21 trading days in Europe and 20 trading days in the U.S. in November 2009.
Derivatives Trading
European Derivatives
NYSE Euronext European derivatives products ADV in November 2010 was 4.4 million futures and options contracts, an increase of 1.6% from November 2009 and an increase of 23.3% from October 2010. The 4.4 million in futures and options contracts ADV in November 2010 consisted of 3.2 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.2 million contracts, or 27.0%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products.
Year-to-date, European derivatives products ADV of 4.9 million contracts was 18.0% above prior year levels. The 4.9 million in futures and options contracts ADV year-to-date consisted of 3.5 million contracts executed through the LIFFE CONNECT trading platform and 1.4 million contracts, or 27.9%, executed through Bclear.
Total fixed income products ADV of 2.0 million contracts in November 2010 decreased 13.5% from November 2009, but increased 0.5% from October 2010. Year-to-date, total fixed income products ADV of 2.4 million contracts was 15.4% above prior year levels.
Total equity products (including Bclear) ADV of 2.3 million contracts in November 2010 increased 18.4% compared to November 2009 and increased 55.9% from October 2010. The 2.3 million contracts in equity products ADV consisted of 1.7 million contracts in individual equity products ADV and 0.6 million contracts in equity index products ADV. The 1.7 million contracts in individual equity products ADV consisted of 1.0 million in futures contracts, which represented a 61.1% increase compared to November 2009 and 0.7 million in options contracts, which represented a 4.5% increase compared to November 2009. The average rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 2.5 million contracts was 20.1% above prior year levels.
Total commodities products ADV of 67,000 contracts in November 2010 increased 51.9% compared to November 2009. Year-to-date, total commodities product ADV of 65,000 contracts was 35.9% above prior year levels.
U.S. Derivatives
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.9 million contracts in November 2010 increased 28.5% compared to November 2009, but decreased 2.1% compared to October 2010. Year-to-date, U.S. equity options ADV of 3.7 million contracts was 42.3% above prior year levels.
Total U.S. consolidated equity options ADV increased 28.9% to 15.7 million contracts in November 2010 compared to November 2009 and increased 3.0% compared to October 2010. Year-to-date, U.S. consolidated equity options ADV of 14.3 million contracts was 6.3% above prior year levels.
NYSE Euronext’s U.S. options exchanges accounted for 24.7% of the total U.S. consolidated equity options trading in November 2010 in-line with November 2009, but down from 25.9% in October 2010.
NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in November 2010 was approximately 19,000 contracts, compared to 22,200 contracts in November 2009. Year-to-date U.S. futures and futures options ADV was 16,500 contracts, a decrease of 6.2% compared to the prior year period.
Cash Trading
European Cash
NYSE Euronext European cash products ADV of 1.5 million transactions in November 2010 increased 16.6% compared to November 2009 and increased 6.9% compared to October 2010.
Year-to-date, European cash products ADV of 1.5 million transactions was 6.4% above prior year levels.
U.S. Cash
NYSE Euronext U.S. cash products handled ADV in November 2010 decreased 4.8% to 2.3 billion shares compared to November 2009 and decreased 1.1% from October 2010.
Year-to-date, U.S. cash products handled ADV was 2.7 billion shares, down 21.4% from prior year levels.
NYSE Euronext’s Tape A matched market share in November 2010 was 36.1%, down from 36.8% in November 2009, but up from 35.2% in October 2010.
Designated Market Maker participation in NYSE-listed stocks in November 2010 was 9.1%, compared to 9.6% in October 2010 and 9.4% in September 2010. Supplemental Liquidity Provider participation in NYSE-listed stocks in November 2010 was 14.6%, compared to 15.4% in October 2010 and 12.4% in September 2010.
Exchange Traded Products
NYSE Euronext U.S. matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 315 million shares in November 2010 increased 1.3% compared to November 2009 and increased 4.3% compared to October 2010. Year-to-date, NYSE Euronext U.S. matched exchange-traded products ADV of 344 million shares was 25.0% below prior year levels.
Discussion about this post